Clinical trials in Utrecht – page 26

616 clinical trials in Utrecht, The Netherlands across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in the NetherlandsKlinischOnderzoek.nl

Utrecht at a glance

616

clinical trials

Research sites5

Quick filters

616 trials in Utrecht

Open in trial search

Skin wrinkling

Not yet recruiting

Study Comparing the Effectiveness and Safety of Botulinum Toxin Type A Products for Treating Frown Lines in Adults

Registered drugNo placebo

Study Comparing the Effectiveness and Safety of Botulinum Toxin Type A Products for Treating Frown Lines in Adults

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Botulinum Toxin Type A
Sponsor:Amsterdam UMC Stichting

Contact Research Centre

Non-small cell lung cancer

Not yet recruiting

Study on Extending Osimertinib Dosing for Patients with EGFR Mutated Advanced Non-Small Cell Lung Cancer

Registered drugNo placebo

Study on Extending Osimertinib Dosing for Patients with EGFR Mutated Advanced Non-Small Cell Lung Cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Osimertinib
Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Contact Research Centre

Squamous cell carcinoma of the oral cavity

Not yet recruiting

Study on Detecting Sentinel Lymph Nodes in Early Oral Cancer Using Gallium-68-Tilmanocept and Technetium-99m in Patients with Oral Cancer

Registered drugNo placebo

Study on Detecting Sentinel Lymph Nodes in Early Oral Cancer Using Gallium-68-Tilmanocept and Technetium-99m in Patients with Oral Cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Technetium (99Mtc)
Sponsor:Universitair Medisch Centrum Utrecht

Contact Research Centre

Neuroblastoma

Not yet recruiting

Study of Anti-GD2-800CW for Imaging in Children with Neuroblastoma

InvestigationalNo placebo

Study of Anti-GD2-800CW for Imaging in Children with Neuroblastoma

InvestigationalNo placebo

The Netherlands

Participants:0–17 years
Substances:ANTI-GD2-800CW
Sponsor:Princess Maxima Center For Pediatric Oncology

Contact Research Centre

Still's disease+1

Not yet recruiting

Study on Anakinra for Children with Systemic Juvenile Idiopathic Arthritis

Registered drugNo placebo

Study on Anakinra for Children with Systemic Juvenile Idiopathic Arthritis

Registered drugNo placebo

The Netherlands

Participants:0–17 years
Substances:Anakinra
Sponsor:Universitair Medisch Centrum Utrecht

Contact Research Centre

Acute myeloid leukaemia

Not yet recruiting

Study on WT1-loaded CBDC Vaccine for Children and Young Adults with Acute Myeloid Leukemia

InvestigationalNo placebo

Study on WT1-loaded CBDC Vaccine for Children and Young Adults with Acute Myeloid Leukemia

InvestigationalNo placebo

The Netherlands

Participants:0–17 years · 18–64 years
Substances:Autologous Cord Blood-Derived Dendritic Cells Loaded With Wt1 Peptide Pool
Sponsor:Princess Maxima Center For Pediatric Oncology

Contact Research Centre

COVID-19

Not yet recruiting

Study on Metformin and Colchicine for Treating Long COVID Symptoms in Patients

Registered drugNo placebo

Study on Metformin and Colchicine for Treating Long COVID Symptoms in Patients

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Colchicine
Sponsor:Universitair Medisch Centrum Utrecht

Contact Research Centre

Systemic lupus erythematosus+1

Not yet recruiting

Study on the Effects of Rapcabtagene Autoleucel in Patients with Systemic Lupus Erythematosus and Active, Refractory Lupus Nephritis

Registered drugNo placebo

Study on the Effects of Rapcabtagene Autoleucel in Patients with Systemic Lupus Erythematosus and Active, Refractory Lupus Nephritis

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Azathioprine
Sponsor:Novartis Pharma AG

Contact Research Centre

Systemic scleroderma

Not yet recruiting

Study comparing rapcabtagene autoleucel and rituximab in patients with severe refractory diffuse cutaneous systemic sclerosis

Registered drugNo placebo

Study comparing rapcabtagene autoleucel and rituximab in patients with severe refractory diffuse cutaneous systemic sclerosis

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide
Sponsor:Novartis Pharma AG

Contact Research Centre

Colorectal cancer metastatic+2

Not yet recruiting

Study on the Effectiveness of Floxuridine in Patients with Resectable Colorectal Liver Metastases and Low Clinical Risk Score

Registered drugNo placebo

Study on the Effectiveness of Floxuridine in Patients with Resectable Colorectal Liver Metastases and Low Clinical Risk Score

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Contact Research Centre

Anal fistula+2

Not yet recruiting

Study on Antibiotic Treatment with Metronidazole and Ciprofloxacin for Patients with Perianal Abscess After Surgery

Registered drug

Study on Antibiotic Treatment with Metronidazole and Ciprofloxacin for Patients with Perianal Abscess After Surgery

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Ciprofloxacin
Sponsor:Amsterdam UMC Stichting

Contact Research Centre

Brain stem glioma+1

Not yet recruiting

Study on ONC201 and Paxalisib for Children and Young Adults with Diffuse Midline Gliomas, Including Diffuse Intrinsic Pontine Gliomas

InvestigationalNo placebo

Study on ONC201 and Paxalisib for Children and Young Adults with Diffuse Midline Gliomas, Including Diffuse Intrinsic Pontine Gliomas

InvestigationalNo placebo

The Netherlands

Participants:0–17 years · 18–64 years
Substances:Dordaviprone
Sponsor:Princess Maxima Center For Pediatric Oncology

Contact Research Centre

Other cities in the Netherlands

The busiest research cities in the country

All 103 cities in the Netherlands

Clinical research in Utrecht

What the registry says about research in the country

01 Cardiovascular Research

Innovative studies focusing on TTR amyloidosis and heart disease treatments, investigating new therapeutic approaches for cardiac conditions. Clinical trials evaluate novel medications for improving patient mobility and cardiac function.

Heart Disease Management
Cardiac Biomarkers
Treatment Efficacy

Research aims to enhance quality of life for patients with hereditary and wild-type ATTR cardiomyopathy.

02 Cancer Research

Comprehensive studies in gastric cancer, bladder cancer, and neuroblastoma, exploring innovative treatment combinations and diagnostic methods.

Immunotherapy Applications
Targeted Therapies
Diagnostic Imaging

Advanced trials combining established treatments with novel approaches to improve patient outcomes.

03 Neurological Disorders

Groundbreaking research in Amyotrophic Lateral Sclerosis and chronic inflammatory conditions, focusing on innovative treatments and disease modification strategies.

Gene-Targeted Therapies
Neurological Function
Disease Progression

Studies aim to develop effective treatments for rare and challenging neurological conditions.

Back to the Netherlands All countries